Krka, d. d. (LJSE:KRKG)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
204.00
-4.00 (-1.92%)
At close: Oct 27, 2025
-1.92%
Market Cap6.35B
Revenue (ttm)1.97B
Net Income (ttm)380.92M
Shares Out30.54M
EPS (ttm)12.42
PE Ratio16.74
Forward PE16.42
Dividend8.25 (4.04%)
Ex-Dividend DateJul 22, 2025
Volume5,664
Average Volume12,252
Open206.00
Previous Close208.00
Day's Range202.00 - 206.00
52-Week Range135.00 - 225.00
Beta0.49
RSI47.68
Earnings DateNov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 11,308
Stock Exchange Ljubljana Stock Exchange
Ticker Symbol KRKG
Full Company Profile

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial Statements

News

There is no news available yet.